Crispr

Prime Editing Mechanisms and Optimization

Investigation of reverse transcriptase engineering and polymerization kinetics to enhance prime editing efficiency and reduce off-target effects in mammalian cells.

RESEARCH GAP FRONTIERS

Base Editing Without Double-Strand Breaks

Development of cytosine and adenine base editors that achieve precise single-nucleotide conversions while minimizing DNA damage responses.

RESEARCH GAP FRONTIERS

In Vivo Delivery via Lipid Nanoparticles

Optimization of ionizable lipid formulations for systemic CRISPR-Cas9 delivery to target tissues with improved biodistribution and reduced immunogenicity.

RESEARCH GAP FRONTIERS

Multiplexed Gene Disruption in Complex Organisms

Engineering of multi-guide RNA systems for simultaneous editing of multiple genomic loci in whole organisms and human tissues.

RESEARCH GAP FRONTIERS

Off-Target Activity Prediction and Mitigation

Computational and experimental approaches to identify, predict, and eliminate unintended genomic cleavage by CRISPR components.

RESEARCH GAP FRONTIERS

CRISPR Immunogenicity and Host Response

Characterization of innate and adaptive immune responses triggered by CRISPR machinery and development of immunoevasion strategies.

RESEARCH GAP FRONTIERS

Epigenetic Editing Without Sequence Changes

Creation of dCas9-based systems for histone modification and DNA methylation remodeling without altering underlying genetic code.

RESEARCH GAP FRONTIERS

CRISPR Screening for Disease Gene Discovery

Genome-wide and targeted CRISPR knockout or activation screens to identify novel genetic factors in human disease pathogenesis.

RESEARCH GAP FRONTIERS

Inducible and Reversible Gene Editing Systems

Development of chemical or light-responsive CRISPR systems enabling temporal control and potential reversal of genetic modifications.

Cell-Type Specific CRISPR Delivery Strategies

Engineering of targeting ligands and promoter systems to achieve CRISPR expression and activity in specialized cell populations.

CRISPR Applications in Oncology and Cancer

Therapeutic targeting of oncogenic mutations and engineering of CAR-T cells using CRISPR for cancer immunotherapy.

Structural Biology of Cas Protein Complexes

Cryo-EM and crystallographic studies of Cas9, Cas12, and other nuclease structures to understand mechanism and guide engineering.

Cas Orthologs from Novel Organisms

Discovery and characterization of Cas proteins from uncultured microorganisms with unique properties for genome editing applications.

RNA-Guided DNA Cleavage Specificity

Mechanistic studies of how guide RNA sequence and structure determine target recognition and cutting accuracy in CRISPR systems.

CRISPR-Based Biosensors and Diagnostics

Development of nucleic acid detection systems using CRISPR components for point-of-care diagnostics and pathogen identification.

PAM Engineering and Expansion

Protein engineering to alter protospacer adjacent motif recognition enabling editing of previously inaccessible genomic sequences.

Heritable Trait Editing in Model Organisms

CRISPR-mediated germline editing in mice, zebrafish, and flies to establish genetic models of human disease.

Therapeutic CRISPR for Inherited Blood Disorders

Clinical translation of CRISPR gene therapy for sickle cell disease, beta-thalassemia, and other hematologic genetic conditions.

CRISPR Repair Pathway Engineering

Modulation of cellular DNA repair mechanisms including homology-directed repair and non-homologous end joining to improve editing outcomes.

Split Intein-Based Cas9 Reconstitution

Development of split Cas9 systems for improved control and reduced toxicity of genome editing in sensitive cell types.

MicroRNA Targeting with CRISPR Systems

Application of CRISPR to modulate miRNA biogenesis or function for therapeutic intervention in disease processes.

Chromatin Accessibility and CRISPR Efficiency

Investigation of how heterochromatin structure and histone modifications affect CRISPR accessibility and editing efficiency.

CRISPR for Neurodegenerative Disease Treatment

Approaches for CNS delivery and correction of genetic mutations underlying Huntington''s disease, Alzheimer''s, and Parkinson''s disease.

Programmable DNA-Binding Proteins Beyond Cas

Engineering of alternative RNA-guided nucleases and zinc finger proteins as orthogonal systems for simultaneous multiplex editing.

CRISPR Mosaicism and Somatic Heterogeneity

Analysis of incomplete editing and variable mutation patterns across cells and tissues following CRISPR treatment.

Viral Vector Systems for CRISPR Delivery

Development and optimization of AAV, lentiviral, and other viral platforms for efficient intracellular CRISPR component delivery.

CRISPR in Plant Genomics and Agriculture

Application of CRISPR for trait improvement, disease resistance, and crop optimization with regulatory and ethical considerations.

Dual-Function RNA Guides for Multiplexing

Engineering of guide RNAs that simultaneously direct multiple Cas proteins or recruit additional regulatory proteins.

CRISPR Toxicity Mechanisms and Solutions

Investigation of Cas protein-induced cellular stress, apoptosis, and p53 activation with strategies to minimize adverse effects.

Machine Learning for Guide RNA Design

Development of artificial intelligence algorithms to predict optimal guide RNA sequences for improved on-target activity and specificity.

CRISPR-Based Gene Drive Systems

Engineering of self-perpetuating genetic elements using CRISPR for population control and genetic disease suppression.

Long Non-Coding RNA Editing Applications

CRISPR-mediated modification of lncRNA sequences and investigation of functional consequences in disease models.

Trans-Splicing and Exon Skipping with CRISPR

Application of CRISPR to modulate pre-mRNA processing for correction of disease-causing mutations through alternative splicing.

CRISPR-Mediated Chromosome Rearrangement

Use of multiple DSBs and CRISPR to engineer large-scale chromosomal deletions, inversions, and translocations.

Single-Cell Analysis of CRISPR Outcomes

High-throughput single-cell RNA-seq and genomic analysis to characterize heterogeneity in editing efficiency and downstream effects.

Organ-on-Chip Models with CRISPR-Edited Cells

Integration of CRISPR-modified primary cells in microfluidic platforms to model human disease and test therapeutics.

RNA Targeting with Cas13 Nucleases

Development and optimization of Cas13-based systems for programmable RNA cleavage and therapeutic targeting of viral or aberrant transcripts.

Metabolic Pathway Engineering via CRISPR

Coordinated editing of multiple metabolic enzymes to enhance bioproduction of pharmaceuticals, fuels, and industrial chemicals.

CRISPR Immunotherapy for Infectious Diseases

Engineering of immune cells using CRISPR to recognize and eliminate viral, bacterial, or parasitic pathogens.

Nuclear and Mitochondrial Genome Editing

Development of mitochondrial-targeted CRISPR systems for treatment of maternal inheritance disorders and energy metabolism diseases.

Temporal Dynamics of CRISPR-Induced Mutations

Real-time characterization of DNA cutting and repair kinetics following CRISPR activation in living cells using advanced microscopy.

CRISPR Activation and Transcriptional Control

Engineering of dCas9-transcription factor fusions for precise activation of endogenous genes without permanent DNA sequence changes.

Combinatorial Drug-CRISPR Therapeutic Synergy

Investigation of enhanced therapeutic effects through combination of CRISPR editing with chemical drugs or biologic therapies.

CRISPR in Rare and Ultra-Rare Genetic Diseases

Development of patient-specific or mutation-specific CRISPR therapies for genetic conditions affecting small populations.

RNA Secondary Structure Impacts on Editing

Studies of how guide RNA and target mRNA folding influence CRISPR binding, recognition, and cleavage efficiency.

Orthogonal Cas Systems for Multiplex Editing

Simultaneous use of structurally distinct Cas nucleases with non-overlapping guide RNA and PAM requirements for parallel editing.

CRISPR-Based Synthetic Biology and Circuits

Engineering of programmable cellular logic circuits using CRISPR components for biosensing and therapeutic decision-making.

Long-Term Safety and Durability of CRISPR Edits

Longitudinal monitoring of genome stability, off-target effects, and phenotypic outcomes following CRISPR treatment in animal models.

CRISPR for Regenerative Medicine Applications

Use of CRISPR-edited stem cells and tissue engineering to restore function in degenerative diseases and traumatic injury.

Codon Optimization for Cas Protein Expression

Rational design of codon-optimized Cas genes for improved expression levels and reduced cellular toxicity in therapeutic applications.

CRISPR-Cas12 and Cas13 Comparative Efficacy

Systematic evaluation of Cas12 and Cas13 nuclease performance across diverse genomic contexts and RNA targeting applications compared to canonical Cas9 systems.

Nanobody-Enhanced CRISPR Targeting and Precision

Development of engineered nanobodies that improve CRISPR specificity through steric hindrance and allosteric modulation of Cas protein activity.

CRISPR Genome Editing in Pluripotent Stem Cells

Investigation of CRISPR efficiency, off-target effects, and developmental consequences in human embryonic and induced pluripotent stem cells.

Photoinducible CRISPR Systems for Spatial Control

Engineering light-responsive CRISPR components that enable spatiotemporal control of gene editing in living tissues and whole organisms.

CRISPR Resistance Mechanisms in Bacterial Populations

Characterization of evolved bacterial defenses against CRISPR-Cas systems and implications for synthetic biology applications.

Circular RNA Production via CRISPR-Mediated Splicing

Development of CRISPR-based strategies to generate therapeutic circular RNAs with improved stability and immunogenic profiles.

CRISPR Off-Target Prediction Using Structural Modeling

Integration of cryo-EM structures and molecular dynamics simulations to predict and minimize CRISPR off-target binding events.

Adenine and Guanine Deaminase Engineering for Base Editing

Rational design and directed evolution of deaminase domains for improved conversion efficiency and reduced bystander editing in base editors.

CRISPR Delivery via Extracellular Vesicles and Exosomes

Optimization of natural and engineered extracellular vesicle systems for efficient CRISPR component packaging and cellular uptake.

CRISPR-Mediated Somatic Mosaicism in Neuronal Tissues

Analysis of editing heterogeneity in post-mitotic neurons and impact on behavioral and cognitive phenotypes following therapeutic gene correction.

Multiplexed CRISPR Screening in Three-Dimensional Organoids

Development of high-throughput pooled CRISPR libraries combined with organoid cultures for context-dependent gene function discovery.

RNA Thermodynamics and CRISPR Guide Stability

Quantitative analysis of guide RNA thermal stability, secondary structures, and their relationship to CRISPR targeting efficiency.

CRISPR-Mediated Gene Therapy for Cystic Fibrosis

Clinical translation research for CRISPR correction of CFTR mutations in airway epithelial cells with assessment of functional restoration.

Transient CRISPR Expression via Messenger RNA Systems

Optimization of in vitro transcribed mRNA encoding CRISPR components for reduced off-targets and controlled temporal editing windows.

CRISPR-Based Immunoprecipitation for Protein Complex Mapping

Development of CRISPR-dCas9 tethering approaches to map protein-protein interactions and chromatin-associated protein complexes.

Palindromic Sequence Challenges in CRISPR Targeting

Investigation of editing efficiency complications arising from palindromic DNA sequences and strategies for overcoming these targeting obstacles.

CRISPR Perturbation Screens for Pathway Identification

Application of large-scale CRISPR interference and activation screens to systematically map signaling pathways in disease models.

Cas9 Protein Engineering for Enhanced Catalytic Activity

Directed evolution and computational design of Cas9 variants with improved DNA cleavage kinetics and nucleotide binding affinity.

CRISPR Tolerance and Adaptation in Eukaryotic Cells

Mechanistic study of cellular adaptations to chronic CRISPR expression including compensatory mutations and epigenetic remodeling.

Therapeutic CRISPR for Duchenne Muscular Dystrophy

Development of CRISPR-based dystrophin restoration approaches combining exon-skipping and prime editing in muscle tissue.

Deep Learning Models for CRISPR Efficiency Prediction

Construction of neural network architectures trained on large CRISPR datasets to predict guide RNA on-target and off-target activity.

CRISPR-Mediated Chromosomal Translocations for Therapy

Controlled induction of beneficial chromosomal rearrangements via simultaneous CRISPR cutting at distant genomic loci for disease correction.

Microfluidic CRISPR Cell Engineering and Selection

Integration of microfluidic platforms with CRISPR delivery for high-throughput single-cell editing and real-time phenotypic selection.

CRISPR Activation for Silenced Tumor Suppressor Genes

Engineering CRISPR-based transcriptional activation systems to reactivate epigenetically silenced tumor suppressors in cancer cells.

RNA-DNA Heteroduplex Recognition in CRISPR Systems

Structural and biochemical characterization of RNA-DNA heteroduplex formation and its role in CRISPR specificity determination.

Organ Tropism Engineering for CRISPR Viral Delivery

Modification of viral capsid proteins and promoter systems to achieve tissue-specific CRISPR delivery in complex multicellular organisms.

CRISPR-Based Approach for Retinal Dystrophy Treatment

Development of subretinal CRISPR delivery methods and gene editing strategies for inherited photoreceptor degeneration diseases.

Epigenetic Memory and Chromatin Remodeling After CRISPR

Investigation of long-term chromatin landscape alterations and heritable epigenetic changes following CRISPR-mediated DNA modifications.

CRISPR-Cas3 Systems for Large Deletions and Rearrangements

Characterization and optimization of Cas3-dependent nuclease systems for programmable large-scale genomic deletions in therapeutic applications.

Conditional CRISPR Systems with Small Molecule Switches

Engineering CRISPR components with ligand-responsive domains enabling chemically controlled temporal and spatial gene editing precision.

CRISPR Screens for Immunotherapy Target Identification

Systematic screening of immune cell genomes using CRISPR to identify novel targetable pathways for enhanced cancer immunotherapy.

PAM-Interacting Domain Mutations in Cas Variants

Structural guided mutagenesis of PAM-binding regions to engineer Cas variants recognizing non-canonical and degenerate PAM sequences.

CRISPR Editing in Hematopoietic Stem Cell Transplantation

Clinical development of ex vivo CRISPR-edited hematopoietic stem cells for treatment of hemoglobinopathies and immunodeficiencies.

DNA Damage Response Integration with CRISPR Pathways

Mechanistic study of how p53, ATM, and other DNA damage sensors modulate CRISPR editing efficiency and cell survival outcomes.

CRISPR-Mediated Synthetic Lethal Screening in Cancer

Genome-wide CRISPR knockout screens combined with oncogenic mutations to discover synthetic lethal gene pairs for cancer therapeutics.

Recombinant Adeno-Associated Virus CRISPR Packaging Limits

Engineering compact CRISPR components and split-systems to overcome AAV packaging constraints for in vivo gene editing applications.

CRISPR-Mediated Metabolic Rewiring in Engineered Microbes

Systematic pathway optimization using multiplexed CRISPR to redirect microbial metabolism toward high-value biofuel and pharmaceutical production.

Immune Cell Engineering via CRISPR CAR-T Modification

Integration of CRISPR-based editing with CAR-T cell engineering to enhance tumor recognition and reduce on-target off-tumor toxicity.

CRISPR RNA Structure Modifications for Stability Improvement

Chemical and structural engineering of guide RNAs including 2''-O-methyl modifications and pseudouridine substitutions for enhanced cellular stability.

Machine Learning Integration with CRISPR Image Analysis

Development of computer vision algorithms trained on high-throughput imaging data to quantify CRISPR editing outcomes at single-cell resolution.

CRISPR-Mediated Angiogenesis Control in Ischemic Disease

Targeted editing of pro- and anti-angiogenic genes to promote vascular regeneration in peripheral arterial disease and myocardial infarction.

Chromatin State-Dependent CRISPR Targeting Efficiency

Correlation analysis between chromatin accessibility markers and CRISPR editing outcomes to predict and enhance site-specific targeting.

CRISPR-Based Genetic Circuit Design and Function

Construction and characterization of multi-layered CRISPR-based genetic logic circuits for programmable cellular computation and biosensing.

Inflammatory Response Modulation After CRISPR Treatment

Systematic investigation of innate immune activation following CRISPR component exposure and strategies for immune evasion in therapeutic contexts.

CRISPR-Mediated Telomere Lengthening and Aging

Engineering CRISPR-based approaches to selectively extend telomere length and assessment of impacts on cellular senescence and aging.

Multiplexed Base Editor Development and Characterization

Design and optimization of dual adenine and cytosine base editors with improved independence and reduced mutual interference effects.

CRISPR Penetrance and Variable Phenotypic Expression

Investigation of genetic background and environmental factors that influence CRISPR editing penetrance and phenotypic severity in vivo.

Cas Protein Localization and Subcellular Compartmentalization

Engineering nuclear localization signals and organelle-targeting sequences to direct CRISPR components to specific cellular compartments.

CRISPR-Based Biosensors for Pathogenic Nucleic Acid Detection

Development of CRISPR-Cas13-based diagnostic platforms for rapid point-of-care detection of viral and bacterial nucleic acids.

Transgenerational Effects of Germline CRISPR Editing

Long-term assessment of hereditary changes, off-target mutations, and epigenetic alterations across generations following germline CRISPR modification.

Cas12 Family Characterization and Applications

Investigation of type II CRISPR-Cas12 nuclease variants, their biochemical properties, PAM requirements, and therapeutic potential across diverse cell types.

In Vivo CRISPR Efficacy in Large Animals

Assessment of CRISPR editing efficiency, biodistribution, and therapeutic outcomes in large mammalian models including non-human primates and canines.

CRISPR-Induced Chromosomal Instability Analysis

Study of unintended large-scale genomic rearrangements, translocations, and chromosomal aberrations resulting from CRISPR-mediated double-strand breaks.

Adenine Base Editor Mutagenesis and Optimization

Development and refinement of adenine deaminase-based editors to improve specificity, reduce off-targets, and enhance conversion efficiency.

CRISPR Editing in Three-Dimensional Tissue Models

Application of CRISPR technologies to engineered tissues, spheroids, and organoids for studying complex cellular interactions and therapeutic outcomes.

RNA-DNA Hybrid Recognition in CRISPR Systems

Mechanistic studies of how CRISPR effector complexes identify and process RNA-DNA hybrid structures during target recognition and cleavage.

Personalized Medicine via CRISPR Patient Stratification

Development of genomic biomarkers and patient selection criteria for CRISPR-based therapeutics tailored to individual mutation profiles.

CRISPR Payload Packaging in Extracellular Vesicles

Engineering of exosomes and microvesicles as natural carriers for CRISPR components to improve cellular uptake and reduce immunogenicity.

Photoinducible CRISPR Activation and Repression

Development of light-responsive CRISPR systems enabling spatiotemporal control of gene editing in living tissues with high precision.

CRISPR-Mediated Telomerase Reactivation Strategies

Investigation of CRISPR approaches to safely reactivate telomerase expression for treating aging-related diseases without oncogenic consequences.

High-Throughput CRISPR Screening in Cancer Models

Large-scale genetic screens using CRISPR libraries to identify synthetic lethal interactions and therapeutic targets in diverse cancer types.

Nanoparticle-CRISPR Complex Characterization Methods

Development of analytical techniques for characterizing physical properties, stability, and cellular behavior of CRISPR-loaded nanoparticle formulations.

CRISPR Off-Target Signature and Prediction Models

Creation of computational algorithms integrating chromatin context, sequence similarity, and cellular factors to predict genome-wide off-target cleavage.

Microhomology-Mediated End Joining After CRISPR

Study of microhomology-mediated end joining mechanisms and their role in generating predictable and unintended mutations following CRISPR cuts.

CRISPR Therapy for Muscular Dystrophy Variants

Tailored CRISPR approaches for different muscular dystrophy subtypes, including exon-skipping strategies and dystrophin restoration methodologies.

Protein Engineering of Modified Cas Variants

Rational design and directed evolution of Cas proteins with altered catalytic rates, DNA binding affinities, and cellular localization properties.

CRISPR Editing Kinetics and Single-Molecule Dynamics

Real-time analysis of CRISPR component binding, scanning, cleavage, and dissociation rates using single-molecule techniques.

Blood-Brain Barrier Crossing Strategies for CRISPR

Innovation in carrier systems and targeting moieties to enable efficient CRISPR delivery across the blood-brain barrier.

CRISPR-Mediated Immunological Memory Enhancement

Engineering T cells and B cells through CRISPR to improve long-term immunity and vaccine response durability.

Homology-Directed Repair Template Optimization

Design of HDR template structures, modifications, and delivery strategies to enhance precise sequence insertion efficiency.

CRISPR for Polyploid and Aneuploid Genome Editing

Specialized CRISPR strategies for editing polyploid crops, cancer cells with numerical chromosomal abnormalities, and aneuploid organisms.

Cas9 Variant Specificity Through Structural Modifications

Engineering of Cas9 structural domains to enhance PAM recognition, narrow off-target activity, and improve targeting accuracy.

CRISPR Screens for Phenotype-to-Genotype Mapping

Integrated functional genomics using CRISPR perturbations to link complex cellular phenotypes to causal genetic variants.

Immune Cell Engineering with Multiplex CRISPR

Simultaneous editing of multiple genes in CAR-T cells and other immune populations to enhance therapeutic efficacy and safety.

CRISPR-Induced DNA Damage Response Timing

Characterization of temporal dynamics of DNA damage checkpoints, p53 activation, and repair pathway engagement following CRISPR cuts.

Cas Protein Nuclear Localization Signal Engineering

Design of improved nuclear import sequences for efficient Cas protein translocation and optimization of editing kinetics.

CRISPR-Based Metabolic Rewiring in Microorganisms

Systematic CRISPR-guided engineering of bacterial and fungal metabolic networks for biofuel and pharmaceutical production.

Mosaic CRISPR Analysis in Developing Organisms

Investigation of CRISPR-induced clonal mosaicism during embryonic development and its effects on tissue patterning and function.

Thermodynamic Stability of Guide RNA-Target Binding

Biophysical studies of RNA secondary structure, melting temperature, and thermodynamic parameters affecting CRISPR targeting efficiency.

CRISPR Applications in Livestock Genetic Improvement

Development of CRISPR strategies for enhancing disease resistance, growth traits, and reproductive efficiency in agricultural animals.

Prime Editor RNA Scaffold Optimization

Engineering of tevopreQ1-based and structured motifs within prime editor RNA to enhance stability and editing efficiency.

CRISPR for Autoimmune Disease Tolerance Induction

CRISPR-mediated editing of immune cells and tissues to restore tolerance and treat autoimmune and inflammatory conditions.

Coupled CRISPR-Based Transcriptomics Profiling

Integration of CRISPR perturbations with high-resolution transcriptional readouts for functional gene network mapping.

Off-Pathway CRISPR Repair Product Analysis

Comprehensive characterization of non-canonical repair outcomes, deletions, and insertions resulting from alternative DNA repair pathways.

CRISPR Targeting of Structural Genomic Variants

Design of editing strategies for correcting large deletions, duplications, inversions, and other structural variations.

Synthetic Lethal Screening with CRISPR Libraries

Comprehensive mapping of genetic dependencies and vulnerability landscapes through large-scale combinatorial CRISPR screens.

CRISPR-Mediated Cellular Reprogramming Acceleration

Enhancement of induced pluripotent stem cell generation and trans-differentiation through CRISPR-based epigenetic remodeling.

PAM-Flexible Cas Variants Discovery and Engineering

Identification and optimization of Cas nucleases with relaxed or alternative PAM requirements for expanded targeting capabilities.

CRISPR in Fungal Pathogen Host Defense

Exploitation of CRISPR systems to manipulate host immune cells for enhanced antifungal immunity and infection control.

Reversible CRISPR Systems Using Degrons

Development of degradation signal-tagged Cas proteins enabling rapid, reversible control of CRISPR activity.

CRISPR Targeting of Repetitive DNA Elements

Specialized approaches for editing interspersed repeats, tandem duplications, and highly homologous genomic loci with high specificity.

High-Dimensional CRISPR Phenotyping Platforms

Development of multi-parametric readout systems combining imaging, omics, and functional assays for comprehensive CRISPR outcome assessment.

CRISPR-Mediated Inflammatory Disease Suppression

Targeting of pro-inflammatory pathways and cytokine regulation through CRISPR editing for treating chronic inflammatory conditions.

Cas13 Multiplexing for Comprehensive RNA Targeting

Design and optimization of multiple guide RNAs for Cas13-based simultaneous targeting of transcript isoforms and splice variants.

CRISPR Epigenetic Memory and Chromatin Remodeling

Investigation of lasting chromatin state changes, histone modifications, and transgenerational epigenetic effects following CRISPR editing.

Non-Homologous End Joining Bias After CRISPR

Analysis of sequence context-dependent repair pathway selection and prediction of NHEJ mutagenesis patterns.

CRISPR for Viral Latency Reactivation Control

Targeted disruption of viral genome integration sites and latency-associated factors for controlling herpes and HIV persistence.

Multiplexed Detection with CRISPR-Based Sensors

Engineering of orthogonal CRISPR detection systems for simultaneous identification of multiple biomarkers or pathogens.

CRISPR Delivery via Attenuated Viral Vectors

Optimization of replication-incompetent viral particles engineered for stable CRISPR component delivery with minimal immune activation.

Fertility and Germline CRISPR Editing Ethics

Comprehensive examination of regulatory frameworks, ethical considerations, and societal implications of heritable human genome editing.

CRISPR-Cas9 Conformational Dynamics During DNA Binding

Investigation of real-time structural transitions in Cas9 protein during target recognition and cleavage through cryo-EM and molecular dynamics simulations.

Adenine and Cytosine Deaminase Engineering for Improved Editing

Development of enhanced deaminase variants with reduced off-target activity and improved catalytic efficiency for precise nucleotide conversion.

CRISPR Delivery to Immune-Privileged Tissues

Novel delivery strategies targeting blood-brain barrier penetration and immune tolerance mechanisms for CNS and ocular CRISPR applications.

PAM-Free CRISPR Nucleases Discovery and Characterization

Identification and validation of novel Cas enzymes that function without sequence-dependent PAM requirements using metagenomics and biochemical screening.

CRISPR-Induced DNA Damage Response Modulation

Study of p53 activation, cell cycle arrest, and apoptotic pathways triggered by CRISPR editing and strategies to suppress unwanted cellular responses.

Programmable RNA-Targeting Cas Systems Beyond Cas13

Development and characterization of alternative Class 2 CRISPR systems targeting diverse RNA substrates with improved specificity and editing capabilities.

CRISPR-Based Multiplexed Protein Degradation Systems

Engineering of dCas9-PROTAC fusion proteins for simultaneous targeting and degradation of multiple disease-associated protein isoforms.

Chromatin Three-Dimensional Structure and CRISPR Accessibility

Integration of Hi-C data and topologically associating domains to predict and enhance CRISPR accessibility in condensed chromatin regions.

CRISPR-Mediated Telomere Maintenance and Extension

Precise editing of telomeric repeats and shelterin complex components to restore cellular senescence resistance in aging-related diseases.

Guide RNA Secondary Structure Optimization Algorithms

Development of computational tools predicting and minimizing mRNA secondary structures affecting guide RNA stability and CRISPR efficiency.

CRISPR Screening for Synthetic Lethal Interactions

Large-scale functional genomics identifying gene pairs whose simultaneous disruption selectively kills cancer cells while sparing normal tissues.

Transient CRISPR Expression via Modified mRNA Delivery

Engineering of pseudouridine and N1-methylpseudouridine modified mRNAs encoding Cas9 for controlled, time-limited gene editing without genomic integration.

CRISPR-Based Biosensors for Biomarker Detection

Development of trans-activating crRNA systems coupled to fluorescent or electrochemical reporters for point-of-care disease diagnostics.

Cas12 Nuclease Engineering for Enhanced PAM Recognition

Rational design and directed evolution of Cas12 variants with expanded and optimized PAM sequences for broader genomic targeting.

CRISPR-Mediated Chromosome Segregation and Stability

Engineering of kinetochore-targeting CRISPR systems for precise chromosome number manipulation and ploidy control in cellular reprogramming.

Off-Target Prediction Using Epigenetic Histone Marks

Integration of ChIP-seq histone modification data with machine learning to predict transcriptionally-active off-target sites.

RNA-DNA Hybrid Recognition by Cas Nucleases

Mechanistic investigation of R-loop formation during CRISPR targeting and engineered Cas variants for enhanced R-loop detection and cleavage.

CRISPR-Based Cellular Reprogramming Without Transcription Factors

Epigenetic remodeling using dCas9-p300 and dCas9-TET fusion proteins to direct cell fate changes through histone acetylation and DNA demethylation.

Multiplexed CRISPR Targeting with Orthogonal sgRNAs

Engineering of non-cross-reactive guide RNAs enabling simultaneous editing of multiple genomic loci with minimal off-target interference.

CRISPR-Mediated Intron-Exon Boundary Editing

Precise targeting of splice sites and cryptic exons for correction of aberrant splicing in inherited disorders like spinal muscular atrophy.

Cas9 Protein Engineering for Reduced Immunogenicity

Codon-harmonization, glycosylation engineering, and PEGylation strategies to minimize innate immune activation and MHC presentation of Cas9.

CRISPR-Targeted Chromatin Remodeling Complex Recruitment

Construction of dCas9 fusion proteins with SNF2, CHD1, and ISWI family proteins for precise chromatin architecture manipulation.

Protein Fragment Complementation with Split-Cas9 Systems

Development of inducible CRISPR systems using split-intein architecture for spatial and temporal control of genome editing.

CRISPR-Mediated Chromatin Loop Remodeling

Engineering of multi-effector dCas9 systems to alter enhancer-promoter looping and establish new regulatory chromatin architectures.

Prediction of CRISPR Editing Efficiency via Deep Learning

Training of convolutional and recurrent neural networks on large-scale CRISPR screening datasets to predict on-target and off-target cutting efficiency.

CRISPR-Cas3 Nucleases for Large-Scale Genomic Deletions

Development of Type III CRISPR systems for programmable excision of multi-kilobase genomic regions with minimal off-target activity.

CRISPR-Mediated Metabolite Sensing and Response Systems

Integration of riboswitches and allosteric RNA devices with CRISPR machinery for metabolite-responsive gene editing in synthetic biology.

Cas9 Nuclear Localization Signal Optimization

Engineering of enhanced NLS sequences and nuclear import pathways to improve Cas9 nuclear accumulation and genome editing efficiency.

CRISPR Targeting of Non-Canonical DNA Structures

Characterization of Cas9 activity against G-quadruplexes, Z-DNA, and triplex structures for therapeutic targeting of tandem repeat expansions.

CRISPR-Based Somatic Mosaicism Quantification Methods

Development of single-molecule sequencing and digital droplet PCR approaches to measure editing efficiency heterogeneity across cell populations.

CRISPR-Mediated Antigen Presentation Enhancement

Engineering of CAR-T cells and dendritic cells via CRISPR to improve MHC presentation and co-stimulatory molecule expression.

Transient Cas9 Expression via In Vivo RNA Circularization

Design of self-circularizing mRNA molecules encoding Cas9 for rapid degradation and reduced cellular toxicity in tissue-specific applications.

CRISPR-Based Regulatory Variant Mapping and Validation

High-throughput editing of noncoding regulatory variants combined with RNA-seq to identify disease-associated regulatory mutations.

Cas13 Multiplexing for Viral RNA Diagnostics

Development of multiplex Cas13 assays targeting conserved viral genome regions for rapid, sensitive detection of emerging pathogens.

CRISPR-Mediated Protein Trafficking and Localization

Engineering of dCas9-targeting peptide fusions to redirect endogenous proteins to specific cellular compartments for functional studies.

Adenine Base Editor Off-Target Adenosine Deaminase Activity

Characterization and minimization of unintended TadA deaminase activity on genomic adenines outside intended edit sites.

CRISPR-Mediated Long-Range Chromosomal Interactions

Multi-dCas9 tethering systems for engineering large-scale chromatin contacts and structural variant formation in model organisms.

CRISPR Delivery via Extracellular Vesicle Engineering

Bioengineering of exosomes and microvesicles with CRISPR cargo and targeting ligands for improved cellular uptake and biodistribution.

CRISPR-Based Nucleotide Variant Discrimination

Design of guide RNAs with single-nucleotide discrimination capability for allele-specific editing of disease-causing mutations.

CRISPR-Mediated MicroRNA Pathway Engineering

Systematic manipulation of miRNA biogenesis pathways via CRISPR to modulate post-transcriptional regulation in disease contexts.

Cas9 Kinetics and Reaction Mechanism Characterization

Detailed biochemical kinetics studies of PAM scanning, DNA melting, and catalytic cleavage steps using stopped-flow spectroscopy.

CRISPR-Based Endogenous Retroelement Silencing

Targeted disruption of LINE-1 and HERV elements to prevent transposition-mediated mutagenesis in somatic and germline tissues.

Machine Learning for CRISPR Toxicity Prediction

Development of classifier models integrating sequence composition, secondary structure, and cellular context to predict cell death following editing.

CRISPR-Mediated Angiogenesis Enhancement in Ischemic Tissue

Simultaneous upregulation of VEGF, HIF1A, and angiopoietin genes via dCas9-VP64 to promote vascular regeneration.

Photocleavable Linker-Modified Guide RNAs for Spatial Control

Engineering of UV-labile CRISPR guide RNAs enabling spatially resolved genome editing through precise light-activated cleavage.

CRISPR-Mediated Fusion Protein Engineering and Characterization

Targeted editing of endogenous genes to introduce in-frame fluorescent or affinity tags for protein localization and interaction studies.

Cas9 Conformational Selectivity for Off-Target Mitigation

Structure-guided engineering of Cas9 variants with reduced DNA binding domain flexibility to minimize promiscuous off-target cleavage.

CRISPR-Mediated Bacterial Microbiota Modification

In situ delivery of CRISPR systems to selectively eliminate pathogenic bacteria while preserving beneficial microbiota members.

CRISPR-Based Phenotype Association Screen in Yeast

Saturation mutagenesis of essential genes combined with growth under selective pressure to identify novel drug targets and gene functions.

CRISPR Targeting of Trinucleotide Repeat Expansions

Precision excision and contraction of pathological CAG, CGG, and GAA repeats in Huntington''s, fragile X, and Friedreich ataxia.